DRW Securities’s Array Biopharma Inc ARRY Stock Holding History

DRW Securities’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,000	Closed	-$163K	–	183
2018 Q1	$163K	Sell	10,000 -5,000	-33%	-$80.1K	0.01%	130
2017 Q4	$192K	Sell	15,000 -5,000	-25%	-$56.9K	0.02%	422
2017 Q3	$246K	Buy	+20,000	New	+$186K	0.08%	44

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

DRW Securities's ARRY Position: Q2 2018 in Review

DRW Securities sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 10,000 shares — an estimated $163K sold.

DRW Securities first reported a position in ARRY in Q3 2017 and held it in 3 quarters. The position peaked at $246K in Q3 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

DRW Securities reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
DRW Securities sold 10,000 Array Biopharma Inc shares in Q2 2018, an estimated $163K.
DRW Securities first reported a position in Array Biopharma Inc in Q3 2017 and held it in 3 quarters.
DRW Securities's Array Biopharma Inc position peaked at $246K in Q3 2017.
223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on DRW Securities's 13F filing for Q2 2018, filed 14 Aug 2018.